IRLABA CEO Kristina Torfgård plans to step down in Q1 2027
IRLAB Therapeutics AB says its CEO Kristina Torfgård informed the board she wishes to step down during the first quarter of 2027.
Gothenburg, September 3, 2026 — IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson’s disease, announces today that Kristina Torfgård has informed the Board of Directors that she wishes to step down from her position as CEO.
She wil…